CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Thermography

Efficacy of computerized infrared imaging analysis to evaluate mammographically suspicious lesions. 📎

Written by CYBERMED LIFE NEWS
Attachments:
Download this file (Efficacy of computerized infrared imaging analysis to evaluate mammographically suspicious lesions..pdf)Efficacy of computerized infrared imaging analysis to evaluate mammographically suspicious lesions..pdf[Efficacy of computerized infrared imaging analysis to evaluate mammographically suspicious lesions.]306 kB
facebook Share on Facebook
Abstract Title:

Efficacy of computerized infrared imaging analysis to evaluate mammographically suspicious lesions.

Abstract Source:

AJR Am J Roentgenol. 2003 Jan;180(1):263-9. PMID: 12490517

Abstract Author(s):

Y R Parisky, A Sardi, R Hamm, K Hughes, L Esserman, S Rust, K Callahan

Article Affiliation:

USC/Norris Cancer Center, 1441 Eastlake Ave., Los Angeles, CA 90033, USA.

Abstract:

OBJECTIVE: The purpose of this clinical trial was to determine the efficacy of a dynamic computerized infrared imaging system for distinguishing between benign and malignant lesions in patients undergoing biopsy on the basis of mammographic findings.

SUBJECTS AND METHODS: A 4-year clinical trial was conducted at five institutions using infrared imaging of patients for whom breast biopsy had been recommended. The data from a blinded subject set were obtained in 769 subjects with 875 biopsied lesions resulting in 187 malignant and 688 benign findings. The infrared technique records a series of sequential images that provides an assessment of the infrared information in a mammographically identified area. The suspicious area is localized on the infrared image by the radiologist using mammograms, and an index of suspicion is determined, yielding a negative or positive result.

RESULTS: In the 875 biopsied lesions, the index of suspicion resulted in a 97% sensitivity, a 14% specificity, a 95% negative predictive value, and a 24% positive predictive value. Lesions that were assessed as false-negative by infrared analysis were microcalcifications, so an additional analysis was performed in a subset excluding lesions described only as microcalcification. In this restricted subset of 448 subjects with 479 lesions and 110 malignancies, the index of suspicion resulted in a 99% sensitivity, an 18% specificity, a 99% negative predictive value, and a 27% positive predictive value. Analysis of infrared imaging performance in all 875 biopsied lesions revealed that specificity was statistically improved in dense breast tissue compared with fatty breast tissue.

CONCLUSION: Infrared imaging offers a safe noninvasive procedure that would be valuable as an adjunct to mammography in determining whether a lesion is benign or malignant.

Study Type : Human Study

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.